Citation
Palomba, Stefano, et al. "Laparoscopic Ovarian Diathermy Vs Clomiphene Citrate Plus Metformin as Second-line Strategy for Infertile Anovulatory Patients With Polycystic Ovary Syndrome: a Randomized Controlled Trial." American Journal of Obstetrics and Gynecology, vol. 202, no. 6, 2010, pp. 577.e1-8.
Palomba S, Falbo A, Battista L, et al. Laparoscopic ovarian diathermy vs clomiphene citrate plus metformin as second-line strategy for infertile anovulatory patients with polycystic ovary syndrome: a randomized controlled trial. Am J Obstet Gynecol. 2010;202(6):577.e1-8.
Palomba, S., Falbo, A., Battista, L., Russo, T., Venturella, R., Tolino, A., Orio, F., & Zullo, F. (2010). Laparoscopic ovarian diathermy vs clomiphene citrate plus metformin as second-line strategy for infertile anovulatory patients with polycystic ovary syndrome: a randomized controlled trial. American Journal of Obstetrics and Gynecology, 202(6), e1-8. https://doi.org/10.1016/j.ajog.2009.11.042
Palomba S, et al. Laparoscopic Ovarian Diathermy Vs Clomiphene Citrate Plus Metformin as Second-line Strategy for Infertile Anovulatory Patients With Polycystic Ovary Syndrome: a Randomized Controlled Trial. Am J Obstet Gynecol. 2010;202(6):577.e1-8. PubMed PMID: 20096821.
TY - JOUR
T1 - Laparoscopic ovarian diathermy vs clomiphene citrate plus metformin as second-line strategy for infertile anovulatory patients with polycystic ovary syndrome: a randomized controlled trial.
AU - Palomba,Stefano,
AU - Falbo,Angela,
AU - Battista,Lucia,
AU - Russo,Tiziana,
AU - Venturella,Roberta,
AU - Tolino,Achille,
AU - Orio,Francesco,
AU - Zullo,Fulvio,
Y1 - 2010/01/22/
PY - 2009/07/26/received
PY - 2009/09/08/revised
PY - 2009/11/24/accepted
PY - 2010/1/26/entrez
PY - 2010/1/26/pubmed
PY - 2010/6/23/medline
SP - 577.e1
EP - 8
JF - American journal of obstetrics and gynecology
JO - Am J Obstet Gynecol
VL - 202
IS - 6
N2 - OBJECTIVE: The purpose of this study was to compare the effectiveness of laparoscopic ovarian diathermy (LOD) vs clomiphene citrate (CC) plus metformin in infertile patients with CC-resistant polycystic ovary syndrome (PCOS). STUDY DESIGN: Fifty primary infertile patients with CC-resistant PCOS were assigned randomly to receive LOD followed by a 6-month observation (group A) or 6-cycle course of CC plus metformin (group B). Reproductive and safety outcomes were analyzed. RESULTS: No significant difference between 2 groups in pregnancy (15/92 women [16.3%] vs 14/107 women [13.1%]; P = .521) and live-birth (13/92 women [14.1%] vs 12/107 women [11.2%]; P = .536) rates per cycle was observed. With the use of a Cox regression analysis, patients under medical treatment, compared with patients who received surgical treatment, had a relative risk of pregnancy of 1.2 (95% confidence interval, 0.61-2.44; P = .582) and a relative risk of live-birth of 1.4 (95% confidence interval, 0.63-2.96; P = .425). CONCLUSION: LOD and CC plus metformin seem to be 2 effective approaches to treat infertility in patients with CC-resistant PCOS.
SN - 1097-6868
UR - https://www.unboundmedicine.com/medline/citation/20096821/Laparoscopic_ovarian_diathermy_vs_clomiphene_citrate_plus_metformin_as_second_line_strategy_for_infertile_anovulatory_patients_with_polycystic_ovary_syndrome:_a_randomized_controlled_trial_
L2 - https://linkinghub.elsevier.com/retrieve/pii/S0002-9378(09)02229-7
DB - PRIME
DP - Unbound Medicine
ER -